New Horizon Health Ltd Sustainability Reports
The company focuses on the research, development, and commercialization of screening products for colorectal cancer, gastric cancer, and cervical cancer. It primarily distributes cancer home-screening tests like ColoClear and Pupu Tube across China.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
LEI: 6556003WN0RS45SU3L67
FIGI: BBG00Z4LK605
1 reports from 2022 to 2022
